Featured Research

from universities, journals, and other organizations

How to divide and conquer 'social network' of cells

Date:
January 11, 2010
Source:
University of Montreal
Summary:
On Noah's Ark animals came in twos: male and female. In human bodies trillions of cells are coupled, too, and so are the molecules from which they are composed. Yet these don't come in twos, they are regrouped into indistinguishable clusters. Because these complex cell networks are the backbone of life -- and illness -- scientists have long searched for ways to splice cell clusters down to their original pairs.

On Noah's Ark animals came in twos: male and female. In human bodies trillions of cells are coupled, too, and so are the molecules from which they are composed. Yet these don't come in twos, they are regrouped into indistinguishable clusters. Because these complex cell networks are the backbone of life -- and illness -- scientists have long searched for ways to splice cell clusters down to their original pairs.

According to a new study in the journal Nature Methods, Université de Montréal scientists Stephen Michnick and Po Hien Ear have managed the feat of dividing cell networks down to their genesis. The discovery could have applications for diseases such as cancer, where blood-thirsty cells could be decoupled to curb their multiplication in the human body.

"We have provided a simple way to decouple one cellular network from another," says Dr. Michnick, a Université de Montréal biochemistry professor and Canada Research Chair in Integrative Genomics. "Once decoupled, we could clearly distinguish what one network was doing versus another."

As part of their study, the researchers reproduced gene networks using baker's yeast -- a cellular organism proven to resemble the critical functions of human cells. "We cut out relationships between cells to see which are crucial and which are not," explains Dr. Michnick. "We found that de-coupling cells permitted growth regulation. One way to attack cancer would be to find molecules that decouple other networks (as we did), slow down its growth and weaken the illness."


Story Source:

The above story is based on materials provided by University of Montreal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ear et al. A general life-death selection strategy for dissecting protein functions. Nature Methods, 2009; 6 (11): 813 DOI: 10.1038/nmeth.1389

Cite This Page:

University of Montreal. "How to divide and conquer 'social network' of cells." ScienceDaily. ScienceDaily, 11 January 2010. <www.sciencedaily.com/releases/2009/11/091109121211.htm>.
University of Montreal. (2010, January 11). How to divide and conquer 'social network' of cells. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2009/11/091109121211.htm
University of Montreal. "How to divide and conquer 'social network' of cells." ScienceDaily. www.sciencedaily.com/releases/2009/11/091109121211.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins